B3GNT2, a Polylactosamine Synthase, Regulates Glycosylation of EGFR in H7721 Human Hepatocellular Carcinoma Cells
A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non‐small‐cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase inhibitor
Insulin/protein kinase B signalling pathway upregulates metastasis-related phenotypes and molecules in H7721 human hepatocarcinoma cell line
Case Report: Osimertinib achieved remarkable and sustained disease control in an advanced non-small-cell lung cancer harboring EGFR H773L/V774M mutation complex
Survival of Listeria monocytogenes Strain H7762 and Resistance to Simulated Gastric Fluid following Exposure to Frankfurter Exudate
Detection of a co-mutation in the epidermal growth factor receptor gene exon 20 H773L/V774M by FoundationOne test and treatment with osimertinib: A case report
Case Report: A Rare EGFR 20 Insertion Variant, P772_H773insGNP Mediates Resistance to Sunvozertinib but Is Sensitive to Furmonertinib
Effect of Different Auxin Concentration on Rooting in Pigeonpea (Cajanus cajan [L.] Millsp.) cv. Manak (H77216) ViaCotyledonary Node Explants
H7780 - Wave Runup and Wind Setup - Computational Model, Program Number 723-X6-M007A
313 Osimertinib tolerance and sustained disease control in recurrent squamous cell lung cancer with rare compound EGFR mutations (G719A and H773L)
